Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2026-03-02 @ 4:11 AM
Study NCT ID:
NCT00979394
Status:
TERMINATED
Last Update Posted:
2010-08-17
First Post:
2009-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Diabetes Care at Austrian GPs
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D003924', 'term': 'Diabetes Mellitus, Type 2'}], 'ancestors': [{'id': 'D003920', 'term': 'Diabetes Mellitus'}, {'id': 'D044882', 'term': 'Glucose Metabolism Disorders'}, {'id': 'D008659', 'term': 'Metabolic Diseases'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}, {'id': 'D004700', 'term': 'Endocrine System Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 1513}}, 'statusModule': {'overallStatus': 'TERMINATED', 'startDateStruct': {'date': '2009-10'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2010-08', 'completionDateStruct': {'date': '2010-01', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2010-08-16', 'studyFirstSubmitDate': '2009-09-17', 'studyFirstSubmitQcDate': '2009-09-17', 'lastUpdatePostDateStruct': {'date': '2010-08-17', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2009-09-18', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2010-01', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Evaluate characteristics or co morbidities being existent for patient with T2D at GP', 'timeFrame': 'Once per patient'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Diabetes Care at GPs in Austria', 'Characteristic of diabetes patients at GPs in Austria'], 'conditions': ['Type 2 Diabetes']}, 'descriptionModule': {'briefSummary': 'This registery should show the medical care of patient with Type 2 Diabetes (T2D) at GP-offices. Furthermore data of co morbidities and risk factors should be evaluated. Objectives of this NIS (cross-sectional study) are:\n\n* To evaluate which characteristics or co-morbidities are being existent for patient with T2D at GP level,\n* To evaluate representative profile of patient with T2D in Austria,\n* To evaluate which medical therapies are used.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'samplingMethod': 'PROBABILITY_SAMPLE', 'studyPopulation': 'GPs', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Diabetes mellitus type II\n\nExclusion Criteria:\n\n* Diabetes mellitus type I\n* Gestation diabetes\n* Induced diabetes'}, 'identificationModule': {'nctId': 'NCT00979394', 'acronym': 'DCA09', 'briefTitle': 'Evaluation of Diabetes Care at Austrian GPs', 'organization': {'class': 'INDUSTRY', 'fullName': 'AstraZeneca'}, 'officialTitle': 'Diabetes Care Austria 2009', 'orgStudyIdInfo': {'id': 'NIS-CAT-DUM-2009/1'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Patients with type 2 diabetes'}]}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Bernhard Ludvig', 'role': 'STUDY_CHAIR', 'affiliation': 'General Hospital Vienna'}, {'name': 'Guntram Schernthaner', 'role': 'STUDY_CHAIR', 'affiliation': 'Krankenanstalt Rudolfsstiftung'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'AstraZeneca', 'class': 'INDUSTRY'}, 'collaborators': [{'name': 'Bristol-Myers Squibb', 'class': 'INDUSTRY'}], 'responsibleParty': {'oldNameTitle': 'MC MD', 'oldOrganization': 'AstraZeneca'}}}}